PDB: 1008 resultsInfo pagesStatus searchChemie searchBIRD

---

7OUB	High resolution structure of Alpha-1-acid glycoprotein bound to potent anti-tumour compound UCN-01 Descriptor: 7-HYDROXYSTAUROSPORINE, Alpha-1-acid glycoprotein 2 Authors: Landin, E.J.B, Williams, C, Crump, M.P. Deposit date: 2021-06-11 Release date: 2021-12-01 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.82 Å) Cite: The structural basis for high affinity binding of alpha 1-acid glycoprotein to the potent antitumor compound UCN-01. J.Biol.Chem., 297, 2021
6XU5	Human myelin protein P2 mutant N2D Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.65 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
1S44	The structure and refinement of apocrustacyanin C2 to 1.6A resolution and the search for differences between this protein and the homologous apoproteins A1 and C1. Descriptor: (4S)-2-METHYL-2,4-PENTANEDIOL, Crustacyanin A1 subunit, GLYCEROL, ... Authors: Habash, J, Helliwell, J.R, Raftery, J, Cianci, M, Rizkallah, P.J, Chayen, N.E, Nneji, G.A, Zagalsky, P.F. Deposit date: 2004-01-15 Release date: 2004-04-27 Last modified: 2023-08-23 Method: X-RAY DIFFRACTION (1.6 Å) Cite: The structure and refinement of apocrustacyanin C2 to 1.3 A resolution and the search for differences between this protein and the homologous apoproteins A1 and C1. Acta Crystallogr.,Sect.D, 60, 2004
1RBP	CRYSTALLOGRAPHIC REFINEMENT OF HUMAN SERUM RETINOL BINDING PROTEIN AT 2 ANGSTROMS RESOLUTION Descriptor: PLASMA RETINOL-BINDING PROTEIN PRECURSOR, RETINOL Authors: Jones, T.A, Newcomer, M.E, Cowan, S.W. Deposit date: 1990-04-02 Release date: 1991-07-15 Last modified: 2017-11-29 Method: X-RAY DIFFRACTION (2 Å) Cite: Crystallographic refinement of human serum retinol binding protein at 2A resolution. Proteins, 8, 1990
7OXW	CrabP2 mutant R30DK31D Descriptor: ACETATE ION, Cellular retinoic acid-binding protein 2, SULFATE ION Authors: Pastok, M.W, Basle, A, Endicott, J.A. Deposit date: 2021-06-23 Release date: 2022-07-13 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.16 Å) Cite: Structural requirements for the specific binding of CRABP2 to cyclin D3 To Be Published
7OXX	CrabP2 mutant R30AK31A Descriptor: Cellular retinoic acid-binding protein 2, SODIUM ION Authors: Tomlinson, C.W.E, Basle, A, Pohl, E. Deposit date: 2021-06-23 Release date: 2022-07-13 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.33 Å) Cite: Structural requirements for the specific binding of CRABP2 to cyclin D3 To Be Published
6XVS	Human myelin protein P2 mutant P38G, unliganded Descriptor: GLYCEROL, Myelin P2 protein Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XU9	Human myelin protein P2 mutant K3N Descriptor: CHLORIDE ION, CITRIC ACID, Myelin P2 protein, ... Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.7 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVR	Human myelin protein P2 mutant L35S Descriptor: Myelin P2 protein, PALMITIC ACID, SULFATE ION Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVE	Engineered beta-lactoglobulin: variant F105L Descriptor: Beta-lactoglobulin Authors: Loch, J.I, Gotkowski, M, Lewinski, K. Deposit date: 2020-01-21 Release date: 2020-01-29 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.15 Å) Cite: Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin. J.Struct.Biol., 210, 2020
6XUA	Human myelin protein P2 mutant K21Q Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-17 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.3 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XW9	Human myelin protein P2 mutant K120S Descriptor: CHLORIDE ION, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-23 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.9 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
1SA8	THE NMR STRUCTURE OF A STABLE AND COMPACT ALL-beta-SHEET VARIANT OF INTESTINAL FATTY ACID-BINDING PROTEIN Descriptor: Fatty acid-binding protein, intestinal Authors: Ogbay, B, DeKoster, G.T, Cistola, D.P. Deposit date: 2004-02-07 Release date: 2004-06-08 Last modified: 2024-05-22 Method: SOLUTION NMR Cite: The NMR structure of a stable and compact all-beta-sheet variant of intestinal fatty acid-binding protein. Protein Sci., 13, 2004
1TOU	Crystal structure of human adipocyte fatty acid binding protein in complex with a non-covalent ligand Descriptor: 2-[(2-OXO-2-PIPERIDIN-1-YLETHYL)SULFANYL]-6-(TRIFLUOROMETHYL)PYRIMIDIN-4-OL, Fatty acid-binding protein, adipocyte Authors: Ringom, R, Axen, E, Uppenberg, J, Lundback, T, Rondahl, L, Barf, T. Deposit date: 2004-06-15 Release date: 2004-08-24 Last modified: 2024-03-13 Method: X-RAY DIFFRACTION (2 Å) Cite: Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors. Bioorg.Med.Chem.Lett., 14, 2004
1TW4	Crystal Structure of Chicken Liver Basic Fatty Acid Binding Protein (Bile Acid Binding Protein) Complexed With Cholic Acid Descriptor: CHOLIC ACID, Fatty acid-binding protein Authors: Nichesola, D, Perduca, M, Capaldi, S, Carrizo, M.E, Righetti, P.G, Monaco, H.L. Deposit date: 2004-06-30 Release date: 2004-11-23 Last modified: 2024-03-13 Method: X-RAY DIFFRACTION (2 Å) Cite: Crystal structure of chicken liver basic Fatty Acid-binding protein complexed with cholic acid Biochemistry, 43, 2004
1TVQ	Crystal Structure of Apo Chicken Liver Basic Fatty Acid Binding Protein (or Bile Acid Binding Protein) Descriptor: Fatty acid-binding protein Authors: Nichesola, D, Perduca, M, Capaldi, S, Carrizo, M.E, Righetti, P.G, Monaco, H.L. Deposit date: 2004-06-30 Release date: 2004-11-23 Last modified: 2024-03-13 Method: X-RAY DIFFRACTION (2 Å) Cite: Crystal structure of chicken liver basic Fatty Acid-binding protein complexed with cholic acid Biochemistry, 43, 2004
7Q19	Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) Descriptor: 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... Authors: Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. Deposit date: 2021-10-18 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.55 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
7Q2N	Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) Descriptor: 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... Authors: Loch, J.I, Barciszewski, J, Lewinski, K. Deposit date: 2021-10-25 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.7 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
7Q2P	Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) Descriptor: 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... Authors: Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. Deposit date: 2021-10-25 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.69 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
7Q18	Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form Descriptor: Beta-lactoglobulin, SULFATE ION Authors: Loch, J.I, Cymborowski, M.T, Minor, W, Lewinski, K. Deposit date: 2021-10-18 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.804 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
7Q17	Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form Descriptor: 1,2-ETHANEDIOL, Beta-lactoglobulin Authors: Loch, J.I, Barciszewski, J, Lewinski, K. Deposit date: 2021-10-18 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.8 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
7Q2O	Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) Descriptor: 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... Authors: Loch, J.I, Barciszewski, J, Lewinski, K. Deposit date: 2021-10-25 Release date: 2022-05-11 Last modified: 2024-01-31 Method: X-RAY DIFFRACTION (1.8 Å) Cite: New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9, 2022
1S2P	The structure and refinement of apocrustacyanin C2 to 1.3A resolution and the search for differences between this protein and the homologous apoproteins A1 and C1 Descriptor: (4S)-2-METHYL-2,4-PENTANEDIOL, Crustacyanin C2 subunit, SULFATE ION Authors: Habash, J, Helliwell, J.R, Raftery, J, Cianci, M, Rizkallah, P.J, Chayen, N.E, NNeji, G.A, Zakalsky, P.F. Deposit date: 2004-01-09 Release date: 2004-03-02 Last modified: 2023-08-23 Method: X-RAY DIFFRACTION (1.3 Å) Cite: The structure and refinement of apocrustacyanin C2 to 1.3 A resolution and the search for differences between this protein and the homologous apoproteins A1 and C1. Acta Crystallogr.,Sect.D, 60, 2004
6XUW	Human myelin protein P2 mutant L27D Descriptor: CHLORIDE ION, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-21 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (2.31 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020
6XVQ	Human myelin protein P2 mutant K31Q Descriptor: CITRIC ACID, Myelin P2 protein, PALMITIC ACID Authors: Ruskamo, S, Lehtimaki, M, Kursula, P. Deposit date: 2020-01-22 Release date: 2020-04-08 Last modified: 2024-01-24 Method: X-RAY DIFFRACTION (1.8 Å) Cite: Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice. J.Biol.Chem., 295, 2020

<45678910111213141516171819>